A multicenter phase II trial of primary prophylactic PEG-rhG-CSF in pediatric patients with solid tumors and non-Hodgkin lymphoma after chemotherapy: An interim analysis.
Junting HuangSuying LuJuan WangLian JiangXuequn LuoXiangling HeYanpeng WuYi WangXiuli ZhuJian ChenYanlai TangKeke ChenXin TianBoyun ShiLanying GuoJia ZhuFeifei SunZijun ZhenYi-Zhuo ZhangPublished in: Cancer medicine (2023)
ClinicalTrials.gov identifier: NCT04547829.